nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CXCL8—pancreatic cancer	0.269	0.774	CbGaD
Ketoprofen—Diphemanil Methylsulfate—Tamoxifen—pancreatic cancer	0.216	0.839	CrCrCtD
Ketoprofen—PTGS2—pancreatic cancer	0.0786	0.226	CbGaD
Ketoprofen—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.0416	0.161	CrCrCtD
Ketoprofen—SLC22A7—Fluorouracil—pancreatic cancer	0.0389	0.164	CbGbCtD
Ketoprofen—ABCC4—Fluorouracil—pancreatic cancer	0.038	0.161	CbGbCtD
Ketoprofen—SLC22A7—Docetaxel—pancreatic cancer	0.0297	0.126	CbGbCtD
Ketoprofen—ABCC4—Sunitinib—pancreatic cancer	0.0289	0.122	CbGbCtD
Ketoprofen—ALB—Erlotinib—pancreatic cancer	0.0163	0.0687	CbGbCtD
Ketoprofen—CYP2C8—Tamoxifen—pancreatic cancer	0.0148	0.0624	CbGbCtD
Ketoprofen—ALB—Irinotecan—pancreatic cancer	0.0147	0.062	CbGbCtD
Ketoprofen—ALB—Fluorouracil—pancreatic cancer	0.0141	0.0595	CbGbCtD
Ketoprofen—CYP2C8—Erlotinib—pancreatic cancer	0.0126	0.0531	CbGbCtD
Ketoprofen—CYP2C8—Fluorouracil—pancreatic cancer	0.0109	0.046	CbGbCtD
Ketoprofen—CYP2C9—Tamoxifen—pancreatic cancer	0.0103	0.0435	CbGbCtD
Ketoprofen—CYP2C9—Fluorouracil—pancreatic cancer	0.00759	0.0321	CbGbCtD
Ketoprofen—Ketorolac—PTGS2—pancreatic cancer	0.000221	0.109	CrCbGaD
Ketoprofen—Carprofen—PTGS2—pancreatic cancer	0.000221	0.109	CrCbGaD
Ketoprofen—Bromfenac—PTGS2—pancreatic cancer	0.000212	0.105	CrCbGaD
Ketoprofen—Tiaprofenic acid—PTGS2—pancreatic cancer	0.00018	0.0889	CrCbGaD
Ketoprofen—Nepafenac—PTGS2—pancreatic cancer	0.000171	0.0846	CrCbGaD
Ketoprofen—Magnesium salicylate—PTGS2—pancreatic cancer	0.000167	0.0826	CrCbGaD
Ketoprofen—Fenbufen—PTGS2—pancreatic cancer	0.000164	0.0809	CrCbGaD
Ketoprofen—Salsalate—PTGS2—pancreatic cancer	0.000142	0.0703	CrCbGaD
Ketoprofen—Suprofen—PTGS2—pancreatic cancer	0.000136	0.0674	CrCbGaD
Ketoprofen—Fenoprofen—PTGS2—pancreatic cancer	0.000118	0.0581	CrCbGaD
Ketoprofen—Mefenamic acid—PTGS2—pancreatic cancer	0.000109	0.0539	CrCbGaD
Ketoprofen—Naproxen—PTGS2—pancreatic cancer	0.000107	0.0529	CrCbGaD
Ketoprofen—Migraine—Doxorubicin—pancreatic cancer	8.64e-05	0.000949	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Irinotecan—pancreatic cancer	8.63e-05	0.000948	CcSEcCtD
Ketoprofen—Fatigue—Irinotecan—pancreatic cancer	8.62e-05	0.000947	CcSEcCtD
Ketoprofen—Paraesthesia—Fluorouracil—pancreatic cancer	8.6e-05	0.000944	CcSEcCtD
Ketoprofen—Alopecia—Docetaxel—pancreatic cancer	8.59e-05	0.000944	CcSEcCtD
Ketoprofen—Pruritus—Sunitinib—pancreatic cancer	8.59e-05	0.000943	CcSEcCtD
Ketoprofen—Constipation—Irinotecan—pancreatic cancer	8.55e-05	0.000939	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	8.54e-05	0.000938	CcSEcCtD
Ketoprofen—Dyspnoea—Fluorouracil—pancreatic cancer	8.54e-05	0.000937	CcSEcCtD
Ketoprofen—Somnolence—Fluorouracil—pancreatic cancer	8.51e-05	0.000935	CcSEcCtD
Ketoprofen—Face oedema—Doxorubicin—pancreatic cancer	8.47e-05	0.00093	CcSEcCtD
Ketoprofen—Erythema—Docetaxel—pancreatic cancer	8.47e-05	0.00093	CcSEcCtD
Ketoprofen—Decreased appetite—Gemcitabine—pancreatic cancer	8.46e-05	0.00093	CcSEcCtD
Ketoprofen—Dyspepsia—Fluorouracil—pancreatic cancer	8.43e-05	0.000926	CcSEcCtD
Ketoprofen—Nausea—Tamoxifen—pancreatic cancer	8.42e-05	0.000924	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	8.41e-05	0.000923	CcSEcCtD
Ketoprofen—Fatigue—Gemcitabine—pancreatic cancer	8.4e-05	0.000922	CcSEcCtD
Ketoprofen—Gastritis—Epirubicin—pancreatic cancer	8.39e-05	0.000922	CcSEcCtD
Ketoprofen—Constipation—Gemcitabine—pancreatic cancer	8.33e-05	0.000915	CcSEcCtD
Ketoprofen—Nausea—Erlotinib—pancreatic cancer	8.33e-05	0.000915	CcSEcCtD
Ketoprofen—Decreased appetite—Fluorouracil—pancreatic cancer	8.32e-05	0.000914	CcSEcCtD
Ketoprofen—Diarrhoea—Sunitinib—pancreatic cancer	8.3e-05	0.000912	CcSEcCtD
Ketoprofen—Dysgeusia—Docetaxel—pancreatic cancer	8.29e-05	0.000911	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	8.27e-05	0.000908	CcSEcCtD
Ketoprofen—Feeling abnormal—Irinotecan—pancreatic cancer	8.24e-05	0.000905	CcSEcCtD
Ketoprofen—Asthma—Epirubicin—pancreatic cancer	8.2e-05	0.0009	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Irinotecan—pancreatic cancer	8.17e-05	0.000898	CcSEcCtD
Ketoprofen—Pancreatitis—Epirubicin—pancreatic cancer	8.04e-05	0.000883	CcSEcCtD
Ketoprofen—Dizziness—Sunitinib—pancreatic cancer	8.02e-05	0.000881	CcSEcCtD
Ketoprofen—Feeling abnormal—Gemcitabine—pancreatic cancer	8.02e-05	0.000881	CcSEcCtD
Ketoprofen—Abdominal pain upper—Doxorubicin—pancreatic cancer	8.01e-05	0.00088	CcSEcCtD
Ketoprofen—Abdominal pain—Irinotecan—pancreatic cancer	7.9e-05	0.000868	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	7.9e-05	0.000868	CcSEcCtD
Ketoprofen—Feeling abnormal—Fluorouracil—pancreatic cancer	7.89e-05	0.000867	CcSEcCtD
Ketoprofen—Anaemia—Docetaxel—pancreatic cancer	7.83e-05	0.00086	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—pancreatic cancer	7.77e-05	0.000853	CcSEcCtD
Ketoprofen—Vomiting—Sunitinib—pancreatic cancer	7.72e-05	0.000847	CcSEcCtD
Ketoprofen—Flurbiprofen—PTGS2—pancreatic cancer	7.67e-05	0.0379	CrCbGaD
Ketoprofen—Rash—Sunitinib—pancreatic cancer	7.65e-05	0.00084	CcSEcCtD
Ketoprofen—Dermatitis—Sunitinib—pancreatic cancer	7.64e-05	0.00084	CcSEcCtD
Ketoprofen—Urticaria—Fluorouracil—pancreatic cancer	7.61e-05	0.000835	CcSEcCtD
Ketoprofen—Headache—Sunitinib—pancreatic cancer	7.6e-05	0.000835	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—pancreatic cancer	7.58e-05	0.000833	CcSEcCtD
Ketoprofen—Palpitations—Docetaxel—pancreatic cancer	7.48e-05	0.000822	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Epirubicin—pancreatic cancer	7.48e-05	0.000822	CcSEcCtD
Ketoprofen—Weight increased—Epirubicin—pancreatic cancer	7.46e-05	0.000819	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—pancreatic cancer	7.44e-05	0.000817	CcSEcCtD
Ketoprofen—Weight decreased—Epirubicin—pancreatic cancer	7.42e-05	0.000814	CcSEcCtD
Ketoprofen—Hypersensitivity—Irinotecan—pancreatic cancer	7.36e-05	0.000809	CcSEcCtD
Ketoprofen—Convulsion—Docetaxel—pancreatic cancer	7.34e-05	0.000806	CcSEcCtD
Ketoprofen—Hypertension—Docetaxel—pancreatic cancer	7.31e-05	0.000803	CcSEcCtD
Ketoprofen—Drowsiness—Epirubicin—pancreatic cancer	7.31e-05	0.000803	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	7.25e-05	0.000796	CcSEcCtD
Ketoprofen—Myalgia—Docetaxel—pancreatic cancer	7.21e-05	0.000792	CcSEcCtD
Ketoprofen—Nausea—Sunitinib—pancreatic cancer	7.21e-05	0.000792	CcSEcCtD
Ketoprofen—Renal failure—Epirubicin—pancreatic cancer	7.18e-05	0.000789	CcSEcCtD
Ketoprofen—Asthenia—Irinotecan—pancreatic cancer	7.17e-05	0.000788	CcSEcCtD
Ketoprofen—Jaundice—Epirubicin—pancreatic cancer	7.12e-05	0.000782	CcSEcCtD
Ketoprofen—Stomatitis—Epirubicin—pancreatic cancer	7.12e-05	0.000782	CcSEcCtD
Ketoprofen—Conjunctivitis—Epirubicin—pancreatic cancer	7.1e-05	0.00078	CcSEcCtD
Ketoprofen—Hypersensitivity—Fluorouracil—pancreatic cancer	7.05e-05	0.000775	CcSEcCtD
Ketoprofen—Dry mouth—Docetaxel—pancreatic cancer	7.05e-05	0.000774	CcSEcCtD
Ketoprofen—Sweating—Epirubicin—pancreatic cancer	7.01e-05	0.00077	CcSEcCtD
Ketoprofen—Asthenia—Gemcitabine—pancreatic cancer	6.99e-05	0.000767	CcSEcCtD
Ketoprofen—Haematuria—Epirubicin—pancreatic cancer	6.97e-05	0.000765	CcSEcCtD
Ketoprofen—Confusional state—Docetaxel—pancreatic cancer	6.97e-05	0.000765	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—pancreatic cancer	6.92e-05	0.00076	CcSEcCtD
Ketoprofen—Oedema—Docetaxel—pancreatic cancer	6.91e-05	0.000759	CcSEcCtD
Ketoprofen—Anaphylactic shock—Docetaxel—pancreatic cancer	6.91e-05	0.000759	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—pancreatic cancer	6.9e-05	0.000758	CcSEcCtD
Ketoprofen—Epistaxis—Epirubicin—pancreatic cancer	6.89e-05	0.000757	CcSEcCtD
Ketoprofen—Pruritus—Gemcitabine—pancreatic cancer	6.89e-05	0.000757	CcSEcCtD
Ketoprofen—Infection—Docetaxel—pancreatic cancer	6.86e-05	0.000754	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—pancreatic cancer	6.86e-05	0.000754	CcSEcCtD
Ketoprofen—Diarrhoea—Irinotecan—pancreatic cancer	6.84e-05	0.000751	CcSEcCtD
Ketoprofen—Agranulocytosis—Epirubicin—pancreatic cancer	6.82e-05	0.000749	CcSEcCtD
Ketoprofen—Shock—Docetaxel—pancreatic cancer	6.8e-05	0.000747	CcSEcCtD
Ketoprofen—Pruritus—Fluorouracil—pancreatic cancer	6.77e-05	0.000744	CcSEcCtD
Ketoprofen—Thrombocytopenia—Docetaxel—pancreatic cancer	6.77e-05	0.000743	CcSEcCtD
Ketoprofen—Drowsiness—Doxorubicin—pancreatic cancer	6.76e-05	0.000743	CcSEcCtD
Ketoprofen—Tachycardia—Docetaxel—pancreatic cancer	6.74e-05	0.000741	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	6.7e-05	0.000736	CcSEcCtD
Ketoprofen—Diarrhoea—Gemcitabine—pancreatic cancer	6.66e-05	0.000732	CcSEcCtD
Ketoprofen—Renal failure—Doxorubicin—pancreatic cancer	6.65e-05	0.00073	CcSEcCtD
Ketoprofen—Dizziness—Irinotecan—pancreatic cancer	6.61e-05	0.000726	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—pancreatic cancer	6.59e-05	0.000724	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—pancreatic cancer	6.59e-05	0.000724	CcSEcCtD
Ketoprofen—Anorexia—Docetaxel—pancreatic cancer	6.59e-05	0.000723	CcSEcCtD
Ketoprofen—Rhinitis—Epirubicin—pancreatic cancer	6.58e-05	0.000722	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—pancreatic cancer	6.57e-05	0.000722	CcSEcCtD
Ketoprofen—Hepatitis—Epirubicin—pancreatic cancer	6.56e-05	0.000721	CcSEcCtD
Ketoprofen—Diarrhoea—Fluorouracil—pancreatic cancer	6.55e-05	0.000719	CcSEcCtD
Ketoprofen—Pharyngitis—Epirubicin—pancreatic cancer	6.51e-05	0.000715	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—pancreatic cancer	6.48e-05	0.000712	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—pancreatic cancer	6.45e-05	0.000708	CcSEcCtD
Ketoprofen—Epistaxis—Doxorubicin—pancreatic cancer	6.38e-05	0.000701	CcSEcCtD
Ketoprofen—Vomiting—Irinotecan—pancreatic cancer	6.36e-05	0.000698	CcSEcCtD
Ketoprofen—Dizziness—Fluorouracil—pancreatic cancer	6.33e-05	0.000695	CcSEcCtD
Ketoprofen—Visual impairment—Epirubicin—pancreatic cancer	6.32e-05	0.000694	CcSEcCtD
Ketoprofen—Agranulocytosis—Doxorubicin—pancreatic cancer	6.31e-05	0.000693	CcSEcCtD
Ketoprofen—Rash—Irinotecan—pancreatic cancer	6.3e-05	0.000692	CcSEcCtD
Ketoprofen—Dermatitis—Irinotecan—pancreatic cancer	6.3e-05	0.000692	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	6.3e-05	0.000691	CcSEcCtD
Ketoprofen—Headache—Irinotecan—pancreatic cancer	6.26e-05	0.000688	CcSEcCtD
Ketoprofen—Insomnia—Docetaxel—pancreatic cancer	6.25e-05	0.000686	CcSEcCtD
Ketoprofen—Paraesthesia—Docetaxel—pancreatic cancer	6.2e-05	0.000682	CcSEcCtD
Ketoprofen—Erythema multiforme—Epirubicin—pancreatic cancer	6.2e-05	0.000681	CcSEcCtD
Ketoprofen—Vomiting—Gemcitabine—pancreatic cancer	6.19e-05	0.00068	CcSEcCtD
Ketoprofen—Dyspnoea—Docetaxel—pancreatic cancer	6.16e-05	0.000677	CcSEcCtD
Ketoprofen—Somnolence—Docetaxel—pancreatic cancer	6.14e-05	0.000675	CcSEcCtD
Ketoprofen—Rash—Gemcitabine—pancreatic cancer	6.14e-05	0.000674	CcSEcCtD
Ketoprofen—Dermatitis—Gemcitabine—pancreatic cancer	6.13e-05	0.000674	CcSEcCtD
Ketoprofen—Tinnitus—Epirubicin—pancreatic cancer	6.12e-05	0.000672	CcSEcCtD
Ketoprofen—Headache—Gemcitabine—pancreatic cancer	6.1e-05	0.00067	CcSEcCtD
Ketoprofen—Flushing—Epirubicin—pancreatic cancer	6.09e-05	0.000669	CcSEcCtD
Ketoprofen—Vomiting—Fluorouracil—pancreatic cancer	6.09e-05	0.000669	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—pancreatic cancer	6.09e-05	0.000668	CcSEcCtD
Ketoprofen—Dyspepsia—Docetaxel—pancreatic cancer	6.08e-05	0.000668	CcSEcCtD
Ketoprofen—Hepatitis—Doxorubicin—pancreatic cancer	6.07e-05	0.000667	CcSEcCtD
Ketoprofen—Rash—Fluorouracil—pancreatic cancer	6.04e-05	0.000663	CcSEcCtD
Ketoprofen—Dermatitis—Fluorouracil—pancreatic cancer	6.03e-05	0.000662	CcSEcCtD
Ketoprofen—Pharyngitis—Doxorubicin—pancreatic cancer	6.02e-05	0.000662	CcSEcCtD
Ketoprofen—Decreased appetite—Docetaxel—pancreatic cancer	6.01e-05	0.00066	CcSEcCtD
Ketoprofen—Headache—Fluorouracil—pancreatic cancer	6e-05	0.000659	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Docetaxel—pancreatic cancer	5.97e-05	0.000655	CcSEcCtD
Ketoprofen—Fatigue—Docetaxel—pancreatic cancer	5.96e-05	0.000654	CcSEcCtD
Ketoprofen—Nausea—Irinotecan—pancreatic cancer	5.94e-05	0.000652	CcSEcCtD
Ketoprofen—Constipation—Docetaxel—pancreatic cancer	5.91e-05	0.000649	CcSEcCtD
Ketoprofen—Chills—Epirubicin—pancreatic cancer	5.89e-05	0.000647	CcSEcCtD
Ketoprofen—Arrhythmia—Epirubicin—pancreatic cancer	5.86e-05	0.000644	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—pancreatic cancer	5.85e-05	0.000643	CcSEcCtD
Ketoprofen—Alopecia—Epirubicin—pancreatic cancer	5.8e-05	0.000637	CcSEcCtD
Ketoprofen—Nausea—Gemcitabine—pancreatic cancer	5.78e-05	0.000635	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—pancreatic cancer	5.74e-05	0.00063	CcSEcCtD
Ketoprofen—Erythema—Epirubicin—pancreatic cancer	5.71e-05	0.000627	CcSEcCtD
Ketoprofen—Feeling abnormal—Docetaxel—pancreatic cancer	5.69e-05	0.000625	CcSEcCtD
Ketoprofen—Nausea—Fluorouracil—pancreatic cancer	5.69e-05	0.000625	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—pancreatic cancer	5.66e-05	0.000622	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Docetaxel—pancreatic cancer	5.65e-05	0.000621	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—pancreatic cancer	5.63e-05	0.000619	CcSEcCtD
Ketoprofen—Flatulence—Epirubicin—pancreatic cancer	5.63e-05	0.000618	CcSEcCtD
Ketoprofen—Tension—Epirubicin—pancreatic cancer	5.6e-05	0.000616	CcSEcCtD
Ketoprofen—Dysgeusia—Epirubicin—pancreatic cancer	5.59e-05	0.000614	CcSEcCtD
Ketoprofen—Nervousness—Epirubicin—pancreatic cancer	5.55e-05	0.000609	CcSEcCtD
Ketoprofen—Abdominal pain—Docetaxel—pancreatic cancer	5.46e-05	0.0006	CcSEcCtD
Ketoprofen—Chills—Doxorubicin—pancreatic cancer	5.45e-05	0.000598	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—pancreatic cancer	5.42e-05	0.000596	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—pancreatic cancer	5.36e-05	0.000589	CcSEcCtD
Ketoprofen—Ill-defined disorder—Epirubicin—pancreatic cancer	5.3e-05	0.000582	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—pancreatic cancer	5.28e-05	0.00058	CcSEcCtD
Ketoprofen—Anaemia—Epirubicin—pancreatic cancer	5.28e-05	0.00058	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—pancreatic cancer	5.21e-05	0.000572	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—pancreatic cancer	5.19e-05	0.00057	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—pancreatic cancer	5.17e-05	0.000568	CcSEcCtD
Ketoprofen—Malaise—Epirubicin—pancreatic cancer	5.15e-05	0.000566	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—pancreatic cancer	5.13e-05	0.000564	CcSEcCtD
Ketoprofen—Vertigo—Epirubicin—pancreatic cancer	5.13e-05	0.000564	CcSEcCtD
Ketoprofen—Hypersensitivity—Docetaxel—pancreatic cancer	5.09e-05	0.000559	CcSEcCtD
Ketoprofen—Palpitations—Epirubicin—pancreatic cancer	5.05e-05	0.000554	CcSEcCtD
Ketoprofen—Asthenia—Docetaxel—pancreatic cancer	4.96e-05	0.000545	CcSEcCtD
Ketoprofen—Convulsion—Epirubicin—pancreatic cancer	4.95e-05	0.000543	CcSEcCtD
Ketoprofen—Hypertension—Epirubicin—pancreatic cancer	4.93e-05	0.000542	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—pancreatic cancer	4.9e-05	0.000539	CcSEcCtD
Ketoprofen—Pruritus—Docetaxel—pancreatic cancer	4.89e-05	0.000537	CcSEcCtD
Ketoprofen—Anaemia—Doxorubicin—pancreatic cancer	4.88e-05	0.000536	CcSEcCtD
Ketoprofen—Myalgia—Epirubicin—pancreatic cancer	4.86e-05	0.000534	CcSEcCtD
Ketoprofen—Anxiety—Epirubicin—pancreatic cancer	4.85e-05	0.000532	CcSEcCtD
Ketoprofen—Discomfort—Epirubicin—pancreatic cancer	4.8e-05	0.000528	CcSEcCtD
Ketoprofen—Malaise—Doxorubicin—pancreatic cancer	4.77e-05	0.000523	CcSEcCtD
Ketoprofen—Dry mouth—Epirubicin—pancreatic cancer	4.75e-05	0.000522	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—pancreatic cancer	4.75e-05	0.000521	CcSEcCtD
Ketoprofen—Diarrhoea—Docetaxel—pancreatic cancer	4.73e-05	0.000519	CcSEcCtD
Ketoprofen—Confusional state—Epirubicin—pancreatic cancer	4.7e-05	0.000516	CcSEcCtD
Ketoprofen—Palpitations—Doxorubicin—pancreatic cancer	4.67e-05	0.000513	CcSEcCtD
Ketoprofen—Oedema—Epirubicin—pancreatic cancer	4.66e-05	0.000512	CcSEcCtD
Ketoprofen—Anaphylactic shock—Epirubicin—pancreatic cancer	4.66e-05	0.000512	CcSEcCtD
Ketoprofen—Infection—Epirubicin—pancreatic cancer	4.63e-05	0.000509	CcSEcCtD
Ketoprofen—Shock—Epirubicin—pancreatic cancer	4.59e-05	0.000504	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—pancreatic cancer	4.58e-05	0.000503	CcSEcCtD
Ketoprofen—Dizziness—Docetaxel—pancreatic cancer	4.57e-05	0.000502	CcSEcCtD
Ketoprofen—Thrombocytopenia—Epirubicin—pancreatic cancer	4.56e-05	0.000501	CcSEcCtD
Ketoprofen—Hypertension—Doxorubicin—pancreatic cancer	4.56e-05	0.000501	CcSEcCtD
Ketoprofen—Tachycardia—Epirubicin—pancreatic cancer	4.55e-05	0.0005	CcSEcCtD
Ketoprofen—Hyperhidrosis—Epirubicin—pancreatic cancer	4.51e-05	0.000495	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—pancreatic cancer	4.5e-05	0.000494	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—pancreatic cancer	4.48e-05	0.000492	CcSEcCtD
Ketoprofen—Discomfort—Doxorubicin—pancreatic cancer	4.44e-05	0.000488	CcSEcCtD
Ketoprofen—Anorexia—Epirubicin—pancreatic cancer	4.44e-05	0.000488	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—pancreatic cancer	4.4e-05	0.000483	CcSEcCtD
Ketoprofen—Vomiting—Docetaxel—pancreatic cancer	4.39e-05	0.000483	CcSEcCtD
Ketoprofen—Rash—Docetaxel—pancreatic cancer	4.36e-05	0.000479	CcSEcCtD
Ketoprofen—Dermatitis—Docetaxel—pancreatic cancer	4.35e-05	0.000478	CcSEcCtD
Ketoprofen—Confusional state—Doxorubicin—pancreatic cancer	4.35e-05	0.000478	CcSEcCtD
Ketoprofen—Headache—Docetaxel—pancreatic cancer	4.33e-05	0.000475	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.31e-05	0.000474	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—pancreatic cancer	4.31e-05	0.000474	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—pancreatic cancer	4.28e-05	0.000471	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.25e-05	0.000466	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—pancreatic cancer	4.24e-05	0.000466	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.22e-05	0.000464	CcSEcCtD
Ketoprofen—Insomnia—Epirubicin—pancreatic cancer	4.22e-05	0.000463	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—pancreatic cancer	4.21e-05	0.000462	CcSEcCtD
Ketoprofen—Paraesthesia—Epirubicin—pancreatic cancer	4.19e-05	0.00046	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.17e-05	0.000458	CcSEcCtD
Ketoprofen—Dyspnoea—Epirubicin—pancreatic cancer	4.16e-05	0.000456	CcSEcCtD
Ketoprofen—Somnolence—Epirubicin—pancreatic cancer	4.14e-05	0.000455	CcSEcCtD
Ketoprofen—Anorexia—Doxorubicin—pancreatic cancer	4.11e-05	0.000452	CcSEcCtD
Ketoprofen—Nausea—Docetaxel—pancreatic cancer	4.1e-05	0.000451	CcSEcCtD
Ketoprofen—Dyspepsia—Epirubicin—pancreatic cancer	4.1e-05	0.000451	CcSEcCtD
Ketoprofen—Decreased appetite—Epirubicin—pancreatic cancer	4.05e-05	0.000445	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.02e-05	0.000442	CcSEcCtD
Ketoprofen—Fatigue—Epirubicin—pancreatic cancer	4.02e-05	0.000441	CcSEcCtD
Ketoprofen—Constipation—Epirubicin—pancreatic cancer	3.99e-05	0.000438	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.93e-05	0.000432	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—pancreatic cancer	3.9e-05	0.000428	CcSEcCtD
Ketoprofen—Paraesthesia—Doxorubicin—pancreatic cancer	3.87e-05	0.000425	CcSEcCtD
Ketoprofen—Dyspnoea—Doxorubicin—pancreatic cancer	3.84e-05	0.000422	CcSEcCtD
Ketoprofen—Feeling abnormal—Epirubicin—pancreatic cancer	3.84e-05	0.000422	CcSEcCtD
Ketoprofen—Somnolence—Doxorubicin—pancreatic cancer	3.83e-05	0.000421	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.81e-05	0.000419	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—pancreatic cancer	3.8e-05	0.000417	CcSEcCtD
Ketoprofen—Decreased appetite—Doxorubicin—pancreatic cancer	3.75e-05	0.000412	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.72e-05	0.000409	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—pancreatic cancer	3.72e-05	0.000408	CcSEcCtD
Ketoprofen—Urticaria—Epirubicin—pancreatic cancer	3.7e-05	0.000407	CcSEcCtD
Ketoprofen—Constipation—Doxorubicin—pancreatic cancer	3.69e-05	0.000405	CcSEcCtD
Ketoprofen—Abdominal pain—Epirubicin—pancreatic cancer	3.68e-05	0.000405	CcSEcCtD
Ketoprofen—Feeling abnormal—Doxorubicin—pancreatic cancer	3.55e-05	0.00039	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.53e-05	0.000387	CcSEcCtD
Ketoprofen—Hypersensitivity—Epirubicin—pancreatic cancer	3.43e-05	0.000377	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—pancreatic cancer	3.43e-05	0.000376	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—pancreatic cancer	3.41e-05	0.000374	CcSEcCtD
Ketoprofen—Asthenia—Epirubicin—pancreatic cancer	3.34e-05	0.000367	CcSEcCtD
Ketoprofen—Pruritus—Epirubicin—pancreatic cancer	3.3e-05	0.000362	CcSEcCtD
Ketoprofen—Diarrhoea—Epirubicin—pancreatic cancer	3.19e-05	0.00035	CcSEcCtD
Ketoprofen—Hypersensitivity—Doxorubicin—pancreatic cancer	3.18e-05	0.000349	CcSEcCtD
Ketoprofen—Asthenia—Doxorubicin—pancreatic cancer	3.09e-05	0.00034	CcSEcCtD
Ketoprofen—Dizziness—Epirubicin—pancreatic cancer	3.08e-05	0.000339	CcSEcCtD
Ketoprofen—Pruritus—Doxorubicin—pancreatic cancer	3.05e-05	0.000335	CcSEcCtD
Ketoprofen—Vomiting—Epirubicin—pancreatic cancer	2.96e-05	0.000325	CcSEcCtD
Ketoprofen—Diarrhoea—Doxorubicin—pancreatic cancer	2.95e-05	0.000324	CcSEcCtD
Ketoprofen—Rash—Epirubicin—pancreatic cancer	2.94e-05	0.000323	CcSEcCtD
Ketoprofen—Dermatitis—Epirubicin—pancreatic cancer	2.94e-05	0.000322	CcSEcCtD
Ketoprofen—Headache—Epirubicin—pancreatic cancer	2.92e-05	0.000321	CcSEcCtD
Ketoprofen—Dizziness—Doxorubicin—pancreatic cancer	2.85e-05	0.000313	CcSEcCtD
Ketoprofen—Nausea—Epirubicin—pancreatic cancer	2.77e-05	0.000304	CcSEcCtD
Ketoprofen—Vomiting—Doxorubicin—pancreatic cancer	2.74e-05	0.000301	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—pancreatic cancer	2.72e-05	0.000299	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—pancreatic cancer	2.72e-05	0.000298	CcSEcCtD
Ketoprofen—Headache—Doxorubicin—pancreatic cancer	2.7e-05	0.000297	CcSEcCtD
Ketoprofen—Nausea—Doxorubicin—pancreatic cancer	2.56e-05	0.000281	CcSEcCtD
Ketoprofen—ALB—Metabolism—ARG2—pancreatic cancer	1.02e-05	0.000158	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GCG—pancreatic cancer	1.02e-05	0.000158	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—JAG2—pancreatic cancer	1.01e-05	0.000157	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.01e-05	0.000156	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	9.98e-06	0.000155	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—AKT1—pancreatic cancer	9.97e-06	0.000155	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.96e-06	0.000154	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MEN1—pancreatic cancer	9.96e-06	0.000154	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.95e-06	0.000154	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SLC2A2—pancreatic cancer	9.89e-06	0.000153	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—SRC—pancreatic cancer	9.88e-06	0.000153	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SMAD4—pancreatic cancer	9.67e-06	0.00015	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—VEGFA—pancreatic cancer	9.63e-06	0.000149	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PRSS1—pancreatic cancer	9.62e-06	0.000149	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—STK11—pancreatic cancer	9.57e-06	0.000148	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NRAS—pancreatic cancer	9.51e-06	0.000147	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SHH—pancreatic cancer	9.5e-06	0.000147	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SRC—pancreatic cancer	9.48e-06	0.000147	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HES1—pancreatic cancer	9.44e-06	0.000146	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IAPP—pancreatic cancer	9.38e-06	0.000145	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFA—pancreatic cancer	9.23e-06	0.000143	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	9.17e-06	0.000142	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—STAT3—pancreatic cancer	9.14e-06	0.000142	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NRAS—pancreatic cancer	9.12e-06	0.000141	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.08e-06	0.000141	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.08e-06	0.000141	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CB—pancreatic cancer	9.04e-06	0.00014	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HSPA1B—pancreatic cancer	9.01e-06	0.00014	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.99e-06	0.000139	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TYMP—pancreatic cancer	8.95e-06	0.000139	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TYMP—pancreatic cancer	8.9e-06	0.000138	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GLP1R—pancreatic cancer	8.87e-06	0.000138	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	8.87e-06	0.000137	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TGFB1—pancreatic cancer	8.84e-06	0.000137	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—DPYD—pancreatic cancer	8.73e-06	0.000135	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	8.68e-06	0.000135	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MYC—pancreatic cancer	8.49e-06	0.000132	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TGFB1—pancreatic cancer	8.47e-06	0.000131	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	8.45e-06	0.000131	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ARG2—pancreatic cancer	8.34e-06	0.000129	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EGFR—pancreatic cancer	8.31e-06	0.000129	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC2A2—pancreatic cancer	8.28e-06	0.000128	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TERT—pancreatic cancer	8.27e-06	0.000128	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—TYMS—pancreatic cancer	8.23e-06	0.000128	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.2e-06	0.000127	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PLAU—pancreatic cancer	8.19e-06	0.000127	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—KRAS—pancreatic cancer	8.18e-06	0.000127	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CD44—pancreatic cancer	8.08e-06	0.000125	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—JAG1—pancreatic cancer	8.06e-06	0.000125	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.91e-06	0.000123	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.91e-06	0.000123	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HIF1A—pancreatic cancer	7.91e-06	0.000123	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TSC2—pancreatic cancer	7.89e-06	0.000122	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KRAS—pancreatic cancer	7.85e-06	0.000122	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.84e-06	0.000122	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	7.76e-06	0.00012	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GCG—pancreatic cancer	7.75e-06	0.00012	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—APOE—pancreatic cancer	7.72e-06	0.00012	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD44—pancreatic cancer	7.66e-06	0.000119	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HSPA1A—pancreatic cancer	7.6e-06	0.000118	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KDR—pancreatic cancer	7.56e-06	0.000117	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	7.52e-06	0.000117	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	7.49e-06	0.000116	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.39e-06	0.000115	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.35e-06	0.000114	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TYMP—pancreatic cancer	7.29e-06	0.000113	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CG—pancreatic cancer	7.28e-06	0.000113	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—STK11—pancreatic cancer	7.28e-06	0.000113	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—pancreatic cancer	7.27e-06	0.000113	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GLP1R—pancreatic cancer	7.22e-06	0.000112	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PIK3CA—pancreatic cancer	7.21e-06	0.000112	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.21e-06	0.000112	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—EGF—pancreatic cancer	7.2e-06	0.000112	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NFKBIA—pancreatic cancer	7.19e-06	0.000112	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GLP1R—pancreatic cancer	7.18e-06	0.000111	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NOTCH1—pancreatic cancer	7.12e-06	0.00011	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—DPYD—pancreatic cancer	7.1e-06	0.00011	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—DPYD—pancreatic cancer	7.06e-06	0.000109	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—pancreatic cancer	6.98e-06	0.000108	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CG—pancreatic cancer	6.97e-06	0.000108	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—NRAS—pancreatic cancer	6.97e-06	0.000108	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—pancreatic cancer	6.96e-06	0.000108	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGF—pancreatic cancer	6.89e-06	0.000107	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.84e-06	0.000106	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	6.74e-06	0.000104	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC2A2—pancreatic cancer	6.7e-06	0.000104	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—APOE—pancreatic cancer	6.7e-06	0.000104	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—pancreatic cancer	6.67e-06	0.000103	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.67e-06	0.000103	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.63e-06	0.000103	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	6.6e-06	0.000102	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.44e-06	9.98e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CD44—pancreatic cancer	6.41e-06	9.94e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CD—pancreatic cancer	6.4e-06	9.93e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.4e-06	9.92e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EGFR—pancreatic cancer	6.35e-06	9.84e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.34e-06	9.83e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.28e-06	9.74e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—TYMS—pancreatic cancer	6.26e-06	9.71e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GCG—pancreatic cancer	6.15e-06	9.53e-05	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—AKT1—pancreatic cancer	6.14e-06	9.52e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CD—pancreatic cancer	6.12e-06	9.49e-05	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.07e-06	9.4e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SMAD4—pancreatic cancer	6.05e-06	9.37e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	6.04e-06	9.37e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.01e-06	9.32e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—pancreatic cancer	6e-06	9.3e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HES1—pancreatic cancer	5.9e-06	9.15e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT1—pancreatic cancer	5.89e-06	9.13e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GLP1R—pancreatic cancer	5.87e-06	9.11e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.86e-06	9.09e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPARG—pancreatic cancer	5.83e-06	9.04e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.83e-06	9.04e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—STK11—pancreatic cancer	5.78e-06	8.96e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—DPYD—pancreatic cancer	5.78e-06	8.96e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CB—pancreatic cancer	5.58e-06	8.65e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CA—pancreatic cancer	5.51e-06	8.54e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	5.48e-06	8.5e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.43e-06	8.41e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.43e-06	8.41e-05	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	5.39e-06	8.36e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CB—pancreatic cancer	5.34e-06	8.28e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	5.31e-06	8.24e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.24e-06	8.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CD44—pancreatic cancer	5.22e-06	8.09e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CD44—pancreatic cancer	5.19e-06	8.04e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TERT—pancreatic cancer	5.17e-06	8.02e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.11e-06	7.92e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—pancreatic cancer	5.1e-06	7.9e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—APOE—pancreatic cancer	5.09e-06	7.9e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.08e-06	7.88e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.06e-06	7.85e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.03e-06	7.8e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GCG—pancreatic cancer	5e-06	7.76e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GCG—pancreatic cancer	4.97e-06	7.71e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TYMS—pancreatic cancer	4.97e-06	7.71e-05	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT1—pancreatic cancer	4.96e-06	7.68e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HIF1A—pancreatic cancer	4.95e-06	7.67e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TSC2—pancreatic cancer	4.93e-06	7.65e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CASP3—pancreatic cancer	4.91e-06	7.61e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APOE—pancreatic cancer	4.83e-06	7.49e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.82e-06	7.48e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCND1—pancreatic cancer	4.78e-06	7.41e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.77e-06	7.4e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CTNNB1—pancreatic cancer	4.73e-06	7.34e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—STK11—pancreatic cancer	4.7e-06	7.29e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—STK11—pancreatic cancer	4.68e-06	7.25e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—pancreatic cancer	4.64e-06	7.19e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	4.63e-06	7.18e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTEN—pancreatic cancer	4.61e-06	7.15e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CG—pancreatic cancer	4.6e-06	7.13e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	4.59e-06	7.11e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT1—pancreatic cancer	4.5e-06	6.98e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—SRC—pancreatic cancer	4.47e-06	6.93e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOTCH1—pancreatic cancer	4.46e-06	6.91e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPARG—pancreatic cancer	4.44e-06	6.88e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.42e-06	6.85e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.39e-06	6.81e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—pancreatic cancer	4.36e-06	6.75e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGF—pancreatic cancer	4.31e-06	6.68e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NRAS—pancreatic cancer	4.3e-06	6.67e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SRC—pancreatic cancer	4.28e-06	6.63e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CD44—pancreatic cancer	4.25e-06	6.58e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—pancreatic cancer	4.17e-06	6.46e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.16e-06	6.45e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STAT3—pancreatic cancer	4.13e-06	6.4e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.12e-06	6.39e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRAS—pancreatic cancer	4.12e-06	6.38e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GCG—pancreatic cancer	4.07e-06	6.31e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TYMS—pancreatic cancer	4.05e-06	6.27e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—APOE—pancreatic cancer	4.04e-06	6.27e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CD—pancreatic cancer	4.04e-06	6.27e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TYMS—pancreatic cancer	4.02e-06	6.24e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTEN—pancreatic cancer	4e-06	6.2e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TGFB1—pancreatic cancer	4e-06	6.2e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—pancreatic cancer	3.83e-06	5.94e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CD—pancreatic cancer	3.83e-06	5.94e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—STK11—pancreatic cancer	3.83e-06	5.93e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.83e-06	5.93e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TGFB1—pancreatic cancer	3.82e-06	5.93e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGFR—pancreatic cancer	3.75e-06	5.81e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—pancreatic cancer	3.7e-06	5.74e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CG—pancreatic cancer	3.65e-06	5.66e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.59e-06	5.57e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—pancreatic cancer	3.54e-06	5.49e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CB—pancreatic cancer	3.52e-06	5.46e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPARG—pancreatic cancer	3.52e-06	5.46e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—pancreatic cancer	3.49e-06	5.41e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CA—pancreatic cancer	3.4e-06	5.27e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CB—pancreatic cancer	3.34e-06	5.18e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.29e-06	5.11e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—pancreatic cancer	3.29e-06	5.1e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—APOE—pancreatic cancer	3.29e-06	5.1e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—APOE—pancreatic cancer	3.27e-06	5.07e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CA—pancreatic cancer	3.25e-06	5.05e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CD—pancreatic cancer	3.21e-06	4.97e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—pancreatic cancer	3.15e-06	4.88e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—pancreatic cancer	3.15e-06	4.88e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.12e-06	4.83e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.1e-06	4.8e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTEN—pancreatic cancer	3.04e-06	4.72e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—pancreatic cancer	3.01e-06	4.67e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.97e-06	4.6e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CTNNB1—pancreatic cancer	2.96e-06	4.59e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CG—pancreatic cancer	2.95e-06	4.58e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTEN—pancreatic cancer	2.89e-06	4.47e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.87e-06	4.44e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPARG—pancreatic cancer	2.85e-06	4.42e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	2.82e-06	4.38e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CB—pancreatic cancer	2.8e-06	4.34e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT1—pancreatic cancer	2.78e-06	4.31e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APOE—pancreatic cancer	2.68e-06	4.15e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SRC—pancreatic cancer	2.68e-06	4.15e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT1—pancreatic cancer	2.66e-06	4.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.61e-06	4.05e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CD—pancreatic cancer	2.6e-06	4.02e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—STAT3—pancreatic cancer	2.58e-06	4e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRAS—pancreatic cancer	2.57e-06	3.99e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.54e-06	3.93e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.42e-06	3.75e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTEN—pancreatic cancer	2.42e-06	3.75e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—pancreatic cancer	2.4e-06	3.72e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFB1—pancreatic cancer	2.39e-06	3.71e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGFR—pancreatic cancer	2.35e-06	3.64e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.33e-06	3.62e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKT1—pancreatic cancer	2.31e-06	3.58e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.28e-06	3.53e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CB—pancreatic cancer	2.26e-06	3.51e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.25e-06	3.5e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—pancreatic cancer	2.24e-06	3.48e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—pancreatic cancer	2.22e-06	3.44e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CA—pancreatic cancer	2.15e-06	3.33e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.12e-06	3.29e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CA—pancreatic cancer	2.04e-06	3.16e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.97e-06	3.05e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTEN—pancreatic cancer	1.96e-06	3.03e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—pancreatic cancer	1.88e-06	2.92e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.85e-06	2.87e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.84e-06	2.84e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKT1—pancreatic cancer	1.75e-06	2.72e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CA—pancreatic cancer	1.7e-06	2.64e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT1—pancreatic cancer	1.66e-06	2.58e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.6e-06	2.48e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKT1—pancreatic cancer	1.39e-06	2.16e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.39e-06	2.15e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CA—pancreatic cancer	1.38e-06	2.14e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.13e-06	1.76e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.13e-06	1.75e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKT1—pancreatic cancer	1.13e-06	1.75e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKT1—pancreatic cancer	9.22e-07	1.43e-05	CbGpPWpGaD
